12.07.2015 Views

The Impact of Pesticides - Academy Publish

The Impact of Pesticides - Academy Publish

The Impact of Pesticides - Academy Publish

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

fauna. Occupational exposure to pesticides may increase the risk for adversereproductive outcomes, brain and nervous system disturbances may causeimmunodepression and lead to cancer in later life and can also induce heritablechanges. Three million cases <strong>of</strong> pesticide poisoning, about 220,000 <strong>of</strong> which arefatal, occur world-wide every year (Raipulis et al., 2009). Of those interviewed in asurvey argentina, 13% did not provide an answer in relation with this issue. Withregards to the place where the accidents took place, they found that 50% were in thegreenhouse, 25% in the open field, and 25% in the shed. As to the body areasaffected, in 52% <strong>of</strong> the cases, intoxication with agrochemicals affected the body ingeneral, whereas in 13% <strong>of</strong> the cases, lesions were produced in eye and 7% in otherbody areas (Paunero et al., 2009).Genotoxicological biomonitoring <strong>of</strong> human populations is a useful tool to estimatethe genetic risk posed by an integrated exposure to complex mixtures <strong>of</strong> chemicals.Cytogenetic studies refer to different typology <strong>of</strong> exposure and provide differentinformation about the genetic risk associated with pesticide exposure. Few studiesare available on acute pesticide exposure in poisoned subjects. <strong>The</strong> large majority <strong>of</strong>cytogenetic monitoring studies in human populations exposed to pesticides concernthe genotoxic effects <strong>of</strong> chronic low doses <strong>of</strong> a single compound or <strong>of</strong> a complexmixture <strong>of</strong> chemicals (Bolognesi, 2003).Biomonitoring and BiomarkersHuman biomonitoring depends on the use <strong>of</strong> biomarkers, defined as quantitativeindicators <strong>of</strong> molecular and cellular events in biological systems, relevant to humanhealth, development and aging. Biomarkers are measured in biological material(generally blood or urine) collected from patients or volunteer subjects inobservational or intervention studies (Collins and Dusinska, 2009). <strong>The</strong> molecularepidemiological approach, which measures molecular or cellular biomarkers asindicators <strong>of</strong> disease risk or <strong>of</strong> exposure to causative or preventive factors, hasapplications in studies <strong>of</strong> environmental and occupational exposure, diseaseetiology, nutrition, lifestyle, and so on. It is a valuable adjunct to conventionalepidemiology, and has the advantage that it requires far fewer subjects and muchless time (and is therefore more economical) than the conventional approach. Inaddition, the biomarkers, if carefully chosen, can give useful information about themolecular mechanisms involved in disease etiology, for example if they reflect anearly stage in the progression <strong>of</strong> the disease (Collins and Dusinska, 2009).A working group formed by IARC (1997) has defined biomarkers as ‘‘anysubstance, structure or process that can be measured in the body or its products andmay influence or predict the incidence or outcome <strong>of</strong> disease’’. This definition isfurther extended by the definition <strong>of</strong> WHO-ICPS (1993).<strong>The</strong> primary purpose <strong>of</strong> using biomarkers <strong>of</strong> effect is surveillance, i.e., theidentification <strong>of</strong> individuals or a population at risk <strong>of</strong> adverse health effects, so thatpreventive measures can be taken. Although a biomarker <strong>of</strong> effect is usually alsorelated to exposure to a specific chemical, it is generally more closely related to theoccurrence <strong>of</strong> an adverse health effect (De Zwart et al., 1999).<strong>The</strong> selection <strong>of</strong> appropriate biomarkers is <strong>of</strong> critical importance because <strong>of</strong> theopportunity for greater precision in the assessment <strong>of</strong> risk in individuals orpopulation sub-groups, with the consequent implications for mitigation and healthprotection. However, this selection will depend upon the state <strong>of</strong> scientificknowledge and be influenced by social, ethical and economic factors. <strong>The</strong> process<strong>of</strong> selection and validation requires careful consideration <strong>of</strong> the specificity andsensitivity <strong>of</strong> the biomarker as a measure <strong>of</strong> the contribution <strong>of</strong> the exposure to an<strong>Academy</strong><strong>Publish</strong>.org - <strong>The</strong> <strong>Impact</strong> <strong>of</strong> <strong>Pesticides</strong>81

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!